化合物 EICAR T71291
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
100 mg | 118908-07-9 | ¥37,500.00 | 询底价 |
25 mg | 118908-07-9 | ¥21,600.00 | 询底价 |
50 mg | 118908-07-9 | ¥28,800.00 | 询底价 |
Product Introduction
Bioactivity
英文名: EICAR
描述: EICAR is a drug which acts as an inhibitor of the enzyme IMP dehydrogenase. It is a nucleoside derivative which has both anti-cancer and antiviral effects, and was originally developed for the treatment of leukemia, but was unsuccessful in human clinical trials. It has broad spectrum antiviral effects with activity against vaccinia virus, Semliki forest virus, Junin virus, reovirus, influenza, measles virus and respiratory syncytial virus among others, although it is not active against SARS. This useful spectrum of activity means that EICAR and related derivatives continue to be investigated for the treatment of viral diseases.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
关键字: EICAR | Nifuroxazide d4
化合物 EICAR T71291信息由TargetMol中国为您提供,如您想了解更多关于化合物 EICAR T71291报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途